Genetic and Environmental Interactions in Obesity and Type 2 Diabetes

Journal of the American Dietetic Association

Volumn 108, Issue 4 SUPPL., 2008, Pages

  Romao, Isabela ^a   Roth, Jesse ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

SIGNAL PEPTIDE;

ARTICLE; ENERGY METABOLISM; ENVIRONMENT; GENETIC PREDISPOSITION; GENETICS; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSIOLOGY; PREVALENCE;

DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; ENVIRONMENT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; OBESITY; PREVALENCE;

EID: 40749085197     PISSN: 00028223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jada.2008.01.022     Document Type: Article

References (35)

1. Mokdad A., Ford E., Bowman B., Dietz W., Vinicor F., Bales V., and Marks J. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289 (2003) 76-79
2. Roth J., Qiang X., Marbán S.L., Redel H., and Lowell B.C. The obesity pandemic: Where have we been and where are we going?. Obes Res 12 (2004) 88S-101S
3. Simon G., Von Korff M., Saunders K., Miglioretti D., Crane P., van Belle G., and Kessler R. Association between obesity and psychiatric disorders in the US adult population. Arch Gen Psychiatry 63 (2006) 824-830
4. UKPDS Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 352 (1998) 837-853
5. Selvin E., Coresh J., Golden S., Brancati F., Folsom A., and Steffes M. Glycemic control and coronary heart disease risk in persons with and without diabetes: The atherosclerosis risk in communities study. Arch Intern Med 165 (2005) 1910-1916
6. Tirosh A., Shai I., Tekes-Manova D., Israeli E., Pereg D., Shochat T., Kochba I., Rudich A., and Israeli Diabetes Research Group. Normal fasting plasma glucose levels and type 2 diabetes in young men. N Engl J Med 353 (2005) 1454
7. Arvanitakis Z., Wilson R.S., Bienias J., Evans D., and Bennett D. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol 61 (2004) 66-76
8. Gustafson D., Rothenberg E., Blennow K., Steen B., and Skoog I. An 18-year follow-up of overweight and risk of Alzheimer disease. Arch Intern Med 163 (2003) 1524-1528
9. Chandalia M., and Abate N. Metabolic complications of obesity: Inflated or inflamed?. J Diabetes Complications 21 (2007) 128-136
10. Coltman D., Mattar S., Barinas-Mitchell E., Eid G., Kuller L., Kelley D., and Schauer P. The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: Implications and effects of weight loss. Obes Surg 14 (2004) 589-600
11. Mussad S., and Haynes E. Biomarkers of obesity and subsequent cardiovascular events. Epidemiol Rev 29 (2007) 98-114
12. Paulsen S.K., Pedersen S.B., Fisher S., and Richelsen B. 11Beta-HSD type 1 expression in human adipose tissue: Impact of gender, obesity, and fat localization. Obesity (Silver Spring) 15 (2007) 1954-1960
13. Fox C., Massaro J., Hoffmann U., Pou K., Maurovich-Horvat P., Liu C., Vasan R., Murabito J., Meigs J., Cupples L., D'Agostino R., and O'Donnell C. Abdominal visceral and subcutaneous adipose tissue compartments: Association with metabolic risk factors in the Framingham Heart Study. Circulation 116 (2007) 39-48
14. Neel J.V. Diabetes mellitus: A "thrifty" genotype rendered detrimental by "progress". Am J Hum Genet 14 (1962) 353-362
15. Bouchard C. The biological predisposition to obesity: Beyond the thrifty genotype scenario. Int J Obes (Lond) 31 (2007) 1337-1339
16. Levine J.A., Schleusner S.J., and Jensen M.D. Energy expenditure of nonexercise activity. Am J Clin Nutr 72 (2000) 1451-1454
17. Stunkard A.J., Sorensen T.I., Hanis C., Teasdale T.W., Chakraborty R., Schull W.J., and Schulsinger F. An adoption study of human obesity. N Engl J Med 314 (1986) 193-198
18. O'Rahilly S., Farooqi I.S., Yeo S., and Challis B.G. Minireview: Human obesity-lessons from monogenic disorders. Endocrinology 144 (2003) 3757-3764
19. Montague C.T., Farooqi I.S., Whitehead J.P., Soos M.A., Rau H., Wareham N.J., Sewter C.P., Digby J.E., Mohammed S.N., Hurst J.A., Cheetham C.H., Earley A.R., Barnett A.H., Prins J.B., and O'Rahilly S. Congenital leptin deficiency is associated with severe early-onset obesity in human. Nature 387 (1997) 903-908
20. List J.F., and Habener J.F. Defective melanocortin 4 receptors in hyperphagia and morbid obesity. N Engl J Med 348 (2003) 1160-1163
21. Wenji Y., Tanika K., and Jian H. Genetic epidemiology of obesity. Epidemiol Rev 29 (2007) 46-61
22. Fajans S.S., Bell G.I., and Polonsky K.S. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 345 (2001) 971
23. Hitman G.A., and Sudagani J. Searching for genes in diabetes and the metabolic syndrome. Int J Clin Pract Suppl 143 (2004) 3-8
24. Frayling T.M. Genome-wide association studies provide new insights into type 2 diabetes aetiology. Nat Rev Genet 8 (2007) 657-662
25. Hill J., and Peters J. Environmental contributions to the obesity pandemic. Science 29 (1998) 1371-1374
26. Willett W. Is dietary fat a major determinant of body fat?. Am J Clin Nutr 67 suppl (1998) 556S-562S
27. Christakis N.A., and Fowler J.H. The Spread of obesity in a large social network over 32 years. N Engl J Med 357 (2007) 379
28. Patel M.S., and Srinivasan M. Metabolic programming: Causes and consequences. J Biol Chem 277 (2002) 1629-1632
29. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346 (2002) 393-403
30. Resnick H., Valsania P., Halter J., and Lin X. Relation of weight gain and weight loss on subsequent diabetes risk in overweight adults. J Epidemiol Community Health 54 (2000) 596-602
31. Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., and Gordon J.L. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444 (2006) 1027-1031
32. Roth J, Qiang X, Liotta A, Shiloach J, Wang H, Ochani M, Ochani K, Yang H, Xu Y, Yuan R, Li J, Yang L, LeRoith D, Lesniak M, Maaser C, Kannengiesser K, Sears C, Donowitz M, Rabizadeh S, Czura C, Schwartz G, Tracey K. Gut bacterium releases endogenous 33AA peptide that mimics alpha-MSH in activating melanocortin receptors of macrophages and neurons. Abstract submitted, 90th Annual Meeting Endocrine Society, San Francisco, CA, June 2008.
33. de la Iglesia N., Mukhtar M., Seoane J., Guinovart J.J., and Agius L. The role of the regulatory protein of glucokinase in the glucose sensory mechanism of the hepatocyte. J Biol Chem 275 (2000) 10597-10603
34. Plum L., Belgardt B.F., and Bruning J.C. Central insulin action in energy and glucose homeostasis. J Clin Invest 116 (2006) 1761-1766
35. Kaput J. Nutrient selection through nutrigenomic approaches. Am J Physiol Regul Integr Comp Physiol 292 (2007) R204-R206